| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |